Investing
Also, Cipla has increased its stake in digital pharma solutions company GoApptiv.
The company announced the appointments of numerous individuals to its executive team and will use the funds to expand its partnerships and oncology platform.
The company will use the funds to prepare for commercialization in the U.S., enhance its platform and seek FDA clearance for its VERAFEYE platform.
Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.
Also, BetterSpace in India has received pre-seed funding to develop mobile mental health games.
The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.
The telehealth company is also betting on secondary care.
Heading into 2024, companies face elevated interest rates, weak liquidity and no appetite from lenders for highly-leveraged capital structures.
The gastrointestinal surgery-focused company will use the funds to advance its endoluminal robotics technology for minimally invasive procedures.
The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.